Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer ; volume:1 ; number:1 ; day:28 ; month:11 ; year:2008 ; pages:1-12 ; date:12.2008
BMC medical genomics ; 1, Heft 1 (28.11.2008), 1-12, 12.2008
- Creator
-
Konstantinopoulos, Panagiotis A.
- Contributor
-
Fountzilas, Elena
Pillay, Kamana
Zerbini, Luiz F.
Libermann, Towia A.
Cannistra, Stephen A.
Spentzos, Dimitrios
SpringerLink (Online service)
- DOI
-
10.1186/1755-8794-1-59
- URN
-
urn:nbn:de:1111-2016071642922
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Konstantinopoulos, Panagiotis A.
- Fountzilas, Elena
- Pillay, Kamana
- Zerbini, Luiz F.
- Libermann, Towia A.
- Cannistra, Stephen A.
- Spentzos, Dimitrios
- SpringerLink (Online service)
Other Objects (12)
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Impact of diabetes mellitus on epithelial ovarian cancer survival
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer
Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Impact of diabetes mellitus on epithelial ovarian cancer survival
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer
Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Impact of diabetes mellitus on epithelial ovarian cancer survival
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer